drugset / Trial / NCT01349868
PT005 MDI Dose Ranging Versus Foradil Aerolizer Study
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of inhaled PT005 MDI compared to placebo and Foradil Aerolizer in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2011-05
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Formoterol | Other / unclassified | 12 ug | — |
| Comparator | Formoterol | Other / unclassified | 24 ug | — |
| Subject | PT005 | Unknown | — | Inhaled |